Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose‐lowering therapy

A Mahdi, O Kövamees, A Checa… - Journal of Internal …, 2018 - Wiley Online Library
Background Arginase is implicated in the pathogenesis behind endothelial dysfunction in
type 2 diabetes mellitus (T2 DM) by its inhibition of nitric oxide formation. Strict glycaemic …

Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus

A Shemyakin, O Kövamees, A Rafnsson, F Böhm… - Circulation, 2012 - Am Heart Assoc
Background—Endothelial dysfunction plays an important role in the early development of
atherosclerosis and vascular complications in type 2 diabetes mellitus. Increased …

Arginase inhibition improves microvascular endothelial function in patients with type 2 diabetes mellitus

O Kövamees, A Shemyakin, A Checa… - The Journal of …, 2016 - academic.oup.com
Objectives: The development of microvascular complications in diabetes is a complex
process in which endothelial dysfunction is important. Emerging evidence suggests that …

Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction

O Kövamees, A Shemyakin… - Diabetes and vascular …, 2016 - journals.sagepub.com
Background: Endothelial dysfunction contributes to the development of vascular
complication in diabetes. Arginase has emerged as a key mechanism behind endothelial …

Improvement in endothelial function in cardiovascular disease-Is arginase the target?

A Mahdi, O Kövamees, J Pernow - International journal of cardiology, 2020 - Elsevier
Endothelial dysfunction represents an early change in the vascular wall in areas prone to
atherosclerotic plaque formation and is present in association with several risk factors for …

Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus

O Kövamees, A Shemyakin, J Pernow - PLoS One, 2014 - journals.plos.org
Background Arginase competes with nitric oxide synthase for their common substrate L-
arginine. Up-regulation of arginase in coronary artery disease (CAD) and diabetes mellitus …

l-Arginine-Induced Vasodilation of the Renal Vasculature Is Not Altered in Hypertensive Patients With Type 2 Diabetes

C Delles, MP Schneider, S Oehmer… - Diabetes …, 2003 - Am Diabetes Assoc
OBJECTIVE—Diabetes, arterial hypertension, hypercholesterolemia, and aging are
associated with endothelial dysfunction in various vasculatures. Endothelium-dependent …

The emerging role of arginase in endothelial dysfunction in diabetes

J Pernow, C Jung - Current vascular pharmacology, 2016 - ingentaconnect.com
Diabetes mellitus is a major risk factor for the development of cardiovascular disease due to
increased vascular inflammatory and oxidative stress favouring atherogenesis. Endothelial …

Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients

R Marfella, R Acampora, G Verrazzo, P Ziccardi… - Diabetes …, 1996 - Am Diabetes Assoc
OBJECTIVE The endothelium plays a pivotal role in the regulation of vascular tone by
releasing nitric oxide (NO). Increased availability of L-arginine, the natural precursor of NO …

L-Citrulline supplementation increases plasma nitric oxide levels and reduces arginase activity in patients with type 2 diabetes

A Shatanawi, MS Momani, R Al-Aqtash… - Frontiers in …, 2020 - frontiersin.org
Type 2 diabetes mellitus (T2DM) is becoming a major contributor to cardiovascular disease.
One of the early signs of T2DM associated cardiovascular events is the development of …